Vaquero-Siguero N., Georgakopoulos N., Puschhof. MC., Jackstadt R. et al. TROP2 targeting reveals therapy-driven cell state dynamics and vulnerabilities in colorectal cancer. Nature 2026 (in press)
Author: Tassilo Steinmann
Combined targeted and epigenetic-based therapy enhances antitumor immunity by stabilizing GATA6-dependent MHCI expression in pancreatic ductal adenocarcinoma
Peng J, Yang J, Antonopoulou G. et al. Combined targeted and epigenetic-based therapy enhances antitumor immunity by stabilizing GATA6-dependent MHCI expression in pancreatic ductal adenocarcinoma. Nat Commun. 2026 (PMID: 41651844)
Delivering precision oncology in metastatic breast cancer: Clinical impact of comprehensive genomic profiling-The CATCH experience
Hlevnjak M, Heublein S, Thewes V. et al. Delivering precision oncology in metastatic breast cancer: Clinical impact of comprehensive genomic profiling-The CATCH experience. Int J Cancer. 2026 (PMID: 41170836)
LiMeTrack: A lightweight biosample management platform for the multicenter SATURN3 consortium
Heyl F., Gassenschmidt J, Heine L, Voigt F., Kleesiek J., Stegle O., Siveke JT., Boerries M., Schwarz RF., Godfrey L. LiMeTrack: A lightweight biosample management platform for the multicenter SATURN3 consortium (under review). bioRxiv 2025. https://doi.org/10.1101/2025.09.01.25334868
PhytClust: efficient and optimalnode clustering in phylogenetic trees
Ganesan K., Billard E., Schwarz RF. PhytClust: efficient and optimal node clustering in phylogenetic trees (under review). bioRxiv 2025. https://doi.org/10.64898/2025.12.11.693738
SATURN3 General Assembly Meeting 2023 – Kick-off Review
A brief look back at our first on site GA Meeting from 23rd to 25th January 2023 in Sonthofen (Germany). In this gathering, the SATURN3 partners came together to network, to align goals and to further shapen the future direction of SATURN3.
SATURN General Assembyl Meeting 2024 – Looking Back
From 29th to 30th January 2024, the SATURN3 team gathered in Mainz (Germany). This annual retreat provided an important platform for strategic updates and collaboration among all SATURN3 members.
SATURN3 early-career researchers selected for the “Rising Stars” Event of the German Federal Ministry for Education, Research, Technology and Space
On 28 October 2025, we (Saturn3 PhD candidate Abir Hussein from Regensburg, postdoctoral researcher Lennart Versemann from Göttingen, surgical resident Karl Knipper from Cologne, and postdoctoral researcher and scientific project coordinator of Saturn3 Vivien Ullrich from Essen), had the exceptional opportunity to participate as one of only 40 selected early-career researchers from across Germany in… Continue reading SATURN3 early-career researchers selected for the “Rising Stars” Event of the German Federal Ministry for Education, Research, Technology and Space
Therapy resistance, recurrence and metastasis: How can resistance be overcome?
An interview with Saturn3 Co-coordinator Prof. Dr. Andreas Trumpp (German Cancer Research Center (DKFZ), Head of Department “Stem Cells and Cancer”, Managing Director of the Stem Cell Institute “HI-STEM gGmbH”) Published in the February 2025 edition of the breast cancer magazine Mamma Mia!: https://mammamia-online.de/shop/brustkrebsmagazin-digital-02-2025 You’re also welcome to take a look at the free guide… Continue reading Therapy resistance, recurrence and metastasis: How can resistance be overcome?
Multimodal survival prediction in advanced pancreatic cancer using machine learning
Keyl J, Kasper S, Wiesweg M, et al. Multimodal survival prediction in advanced pancreatic cancer using machine learning (PMID: 35988455). ESMO Open. Epub 2022.
